Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8771-8780 Newer>

Pharmaceutical Executive February 1, 2014 Jill Wechsler	Drug Coverage, Costs Under Scrutiny Benefits offered by insurance plans on health exchanges and through Medicare are raising concerns about patient access to needed therapies
Pharmaceutical Executive February 1, 2014 William Looney	Russian Innovation: A Higher Mark For the first time, the spotlight shines on Russia's potential in biotechnology and pharma products
Pharmaceutical Executive February 1, 2014 William Looney	A Spark From GSK Today, there is promise in new approaches that rely on the "other language of biology," using the human body's own circuitry of cells and nerves to induce precisely targeted therapeutic effects against a range of debilitating diseases.
CRM February 2014 Leonard Klie	IVR Is the Right Prescription for a Native American Health System Muscogee Creek Nation's Enacomm solution overcomes the challenge of spiking call volumes.
Chemistry World January 31, 2014 Derek Lowe	Beelzebub Pharma Ltd What if I were put in charge of a chemistry research site and wanted to absolutely run it into the ground?
Chemistry World January 30, 2014 Phillip Broadwith	AstraZeneca ends R&D in India Pharmaceutical firm AstraZeneca is quitting its R&D site in Bangalore, India.
Chemistry World January 28, 2014 Phillip Broadwith	Actavis sells off Chinese subsidiary Generic drugs heavyweight Actavis is selling off a subsidiary based in Foshan, China. The business is being bought by Zhejiang Chiral Medicine Chemicals for an undisclosed sum.
Chemistry World January 27, 2014 Phillip Broadwith	US blocks imports from fourth Ranbaxy plant The US Food and Drug Administration has banned Indian drugmaker Ranbaxy from importing active pharmaceutical ingredients produced at its plant at Toansa, India, into the US.
Chemistry World January 27, 2014 Jennifer Newton	Jazz spending spree has ups and downs Jazz Pharmaceuticals has agreed with Aerial Bio Pharma to acquire the rights to ADX-N05, a drug designed to treat narcolepsy.
Chemistry World January 24, 2014 Phillip Broadwith	Novartis and DSM trim jobs Pharmaceutical firm Novartis and nutritional products specialist DSM are both set to cut jobs in Switzerland.
<Older 8771-8780 Newer> Return to current articles.